Trademark: 97070782
Word
ADVARRA
Status
Registered
Status Code
700
Status Date
Tuesday, November 29, 2022
Serial Number
97070782
Registration Number
6910756
Registration Date
Tuesday, November 29, 2022
Mark Type
4000
Filing Date
Tuesday, October 12, 2021
Published for Opposition
Tuesday, September 13, 2022

Trademark Owner History
Advarra, Inc. - Original Registrant

Classifications
41 Providing online education, namely, providing online courses of instruction from a computer database or via the internet or extranet in the fields of clinical trials; developing, arranging, and conducting educational conferences in the field of clinical, medical, and biological research studies; educational services, namely, providing online, non-downloadable webinars, seminars, and conferences in the field of clinical, medical, and biological research studies; non-downloadable electronic publications in the nature of articles, blog posts, case studies, and e-learning modules in the field of clinical, medical, and biological research studies; developing, arranging and conducting business conferences in the field of clinical, medical, and biological research studies
9 Downloadable electronic publications in the nature of articles, case studies, and e-learning modules in the field of clinical, medical, and biological research studies
38 Providing an on-line discussion platform and document sharing platform in the nature of an on-line forum for transmission of messages and information among computer users concerning oncology, cancer research, and general medical and health topics
36 Financial advisory services, namely, budget negotiation and budget set-up services in the field of clinical trials involving human subjects; insurance coverage consultancy services, namely, determining whether particular goods and services in clinical trials are covered by Medicare
35 Business consulting; business administrative assistance, namely, business support services for the preparation and filing of institutional biosafety committee and institutional review board forms for use in the field of human subject research; business management consultation services concerning organization transformation in the field of clinical trials involving human subjects; professional staffing services in the field of medical and scientific research; organizing and administering a network of research sites, namely, business consultation and management in the field of clinical trials, specifically, providing governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes
45 Providing regulatory compliance consultation services in the nature of advice concerning due diligence, strategic development, and regulatory policy in the field of clinical trials involving human subjects; providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; providing information relating to regulatory compliance for independent review of clinical trials involving human subjects; providing institutional biosafety committee services, namely, independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects; regulatory compliance consultation services in the nature of health inspection readiness and remediation in the field of clinical, medical, and biological research studies; consultation services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants; consultation services in the field of research compliance, namely, regulatory compliance consultation services in the field of clinical trials involving human subjects
42 Providing information in the field of medical and scientific research on the internet; providing digital content, namely, e-learning solutions in the nature of software as a service (SAAS) services featuring software for database management and information management relating to clinical trials, on the internet; providing temporary use of on-line non-downloadable software for use by clinical, medical, and biological researchers, research sponsors and clinical research organizations for use in automating the submission, review and approval process of human subject clinical research projects and providing access to forms and templates to researchers, research sponsors and clinical research organizations for automating the submission, review and approval of human subject clinical research projects; providing temporary use of non-downloadable computer software for use in healthcare and research for the management and administration of research for the protection of research participants by automating the conduct of research studies and consent of research participants; providing institutional biosafety committee services, namely, review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, evaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, testing, analysis, and evaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards; consultation services in the nature of quality management, namely, quality evaluation and analysis, quality assurance, and quality control in the field of clinical, medical, and biological research studies; consultation services in the field of drug and medical device development; consultation services in the field of conducting clinical trials for others; consultation services in the field of scientific research compliance, namely, analysis and evaluation of scientific research of others in the field of clinical trials involving human subjects to assure compliance with industry standards; consultation services in the field of scientific research administration and operations in the field of clinical trials involving human subjects; consultation services in the field of product research and development and scientific research and development; consulting services in the field of medical and scientific research for clinical trials; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff for use in the design, administration, and tracking of clinical, medical, and biological research studies; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff in the storage, analysis, and transfer of data related to clinical, medical, and biological research studies; providing online non-downloadable software for use in collecting and managing consents from participants in clinical, medical, and biological research studies; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff in regulatory reporting, compliance tracking, safety monitoring, and evaluation of clinical, medical, and biological research studies; providing online non-downloadable software enabling real-time communication for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, research site staff, and institutional review boards in clinical, medical, and biological research studies; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff in managing stipends and travel reimbursements in clinical, medical, and biological research studies; providing online non-downloadable software for use by pharmaceutical companies and clinical, medical, and biological research study sponsors, and contract research organizations in the design and administration of scientific and medical research projects and of clinical trials for pharmaceuticals, medical devices and medical procedures; providing online non-downloadable software for use by pharmaceutical companies and clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff for data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; providing online non-downloadable software in the nature of a support platform for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, research site staff, study teams and patients for use in information management in the performance of a clinical trial; providing online non-downloadable software in the nature of a clinical trial management system for data processing and information management for use by academic medical centers and cancer centers; providing online non-downloadable software in the nature of a clinical trial management system for data processing and information management for use by clinical, medical, and biological research sites, site networks, hospitals, and health systems; providing online non-downloadable teaching software system in the nature of an e-learning apparatus support platform for content delivery, patient recruitment management, and learning process management and reporting for use by clinical, medical, and biological research site staff, study teams and patients relating to clinical trials; providing online non-downloadable software for patient identification for use by clinical, medical, and biological researchers for patients enrolled in clinical trials; providing online non-downloadable software for patient scheduling and tracking for use by clinical, medical, and biological research sites and patients enrolled in clinical trials; troubleshooting of computer software problems; providing temporary use of non-downloadable cloud-based software for transmitting clinical trial data; business technology software consultation services regarding the implementation of computer software provided online for use in healthcare and research that is for the management and administration of research, the protection of research participants, and the automation and facilitation of the conduct of research studies and electronic consent of research participants; providing online education, namely, software as a service (SAAS) services featuring e-learning software for providing online courses of instruction relating to clinical trials in the field of medicine

Trademark Events
Jan 25, 2023
Assignment Of Ownership Not Updated Automatically
Nov 29, 2022
Notice Of Registration Confirmation Emailed
Nov 29, 2022
Registered-Principal Register
Nov 2, 2022
Assignment Of Ownership Not Updated Automatically
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2022
Published For Opposition
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Aug 9, 2022
Approved For Pub - Principal Register
Aug 9, 2022
Examiner's Amendment Entered
Aug 9, 2022
Notification Of Examiners Amendment E-Mailed
Aug 9, 2022
Examiners Amendment E-Mailed
Aug 9, 2022
Examiners Amendment -Written
Jul 29, 2022
Teas/Email Correspondence Entered
Jul 29, 2022
Correspondence Received In Law Office
Jul 29, 2022
Teas Response To Office Action Received
Feb 14, 2022
Notification Of Non-Final Action E-Mailed
Feb 14, 2022
Non-Final Action E-Mailed
Feb 14, 2022
Non-Final Action Written
Dec 23, 2021
Assigned To Examiner
Nov 2, 2021
New Application Office Supplied Data Entered
Oct 15, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24